Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

by Lai XX, Xu RA, Li YP, Yang H
Published 2016-04-01

Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo

by Lin QM, Xie S, Qiu X, Chen J, Xu RA
Published 2019-04-01

The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro

by Xu RA, Gu EM, Liu TH, Ou-yang QG, Hu GX, Cai JP
Published 2018-11-01

The changes of expressive levels of IL-17A, STAT3, and RORγt in different invasive pulmonary aspergillosis mice

by Xu LN, Xu RA, Zhang D, Su SS, Xu HY, Wu Q, Li YP
Published 2018-08-01

Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine

by Xu RA, Gu EM, Zhou Q, Yuan LJ, Hu XX, Cai JP, Hu GX
Published 2016-02-01

Functional characteristics of CYP3A4 allelic variants on the metabolism of loperamide in vitro

by Lin QM, Li YH, Liu Q, Pang NH, Xu RA, Cai JP, Hu GX
Published 2019-09-01

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro

by Wang Z, Wang L, Xu RA, Zhan YY, Huang CK, Dai DP, Cai JP, Hu GX
Published 2016-06-01

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo

by He JY, Fang P, Zheng X, Wang CC, Liu TH, Zhang BW, Wen J, Xu RA
Published 2018-03-01